がん免疫療法治療中のメチルフェニデートと身体活動による倦怠感管理
Sriram Yennurajalingam1, Bryan Fellman2, Lisa Williams1
1Department of Palliative Care, Rehabilitation, and Integrative Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Palliative & supportive care
|December 21, 2025
まとめ
メチルフェニデート(MP)と身体活動(PA)の併用は、進行がん患者の癌関連倦怠感(CRF)を有意に改善しました。この併用療法は、免疫療法患者の重度の倦怠感管理に有望な新しい道を開きます。
科学分野:
- 腫瘍学
- 薬理学
- 運動生理学
背景:
- 癌関連倦怠感(CRF)は、免疫療法を受けている進行がん患者において一般的で衰弱性の症状です。
- 重度のCRFに対する効果的な治療法は限られており、患者の生活の質に影響を与えています。
主な方法:
- 抗PD1免疫療法を受けている重度のCRFを持つ進行がん患者を対象としたパイロット無作為化比較試験。
- 参加者は、14日間MP + PAまたは対照群 + PAのいずれかを受けるように無作為に割り当てられました。
- 主要評価項目は、癌治療における機能的評価(FACIT-F)スコアの変化でした。副次評価項目には、その他の倦怠感および気分評価が含まれていました。
結論:
- メチルフェニデートと身体活動の併用は、癌関連倦怠感に対する効果的な介入として期待されます。
- MP + PAの併用は、倦怠感の次元とうつ病の改善を含む、より広範な利益をもたらす可能性があります。
- より大規模な比較研究でこれらの所見を確認するために、さらなる研究が必要です。
関連する概念動画
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Cardiomyopathy VI: Nursing Management
296
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
296
Muscle Recovery and Fatigue
3.9K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
3.9K
Myocarditis IV: Nursing Management
194
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
194


